Last reviewed · How we verify

NCT03055182: OXYLOM

Oxygenation of Paravertebral Muscles During Exercise in Chronic Low Back Pain Patients

Completed NA Last updated 23 December 2025
What this trial tests

NA trial testing Physical rehabilitation program in Low Back Pain in 33 participants. Completed in 10 December 2024.

Timeline
11 January 2017
Primary endpoint
10 December 2024
10 December 2024

Quick facts

Lead sponsorUniversity Hospital, Lille
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designfactorial
Maskingnone
Primary purposebasic science
Enrollment33
Start date11 January 2017
Primary completion10 December 2024
Estimated completion10 December 2024
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Lille

Who can join

Adults 20 to 60, any sex, with Low Back Pain or Rehabilitation Program. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study evaluate paraspinal aerobic metabolism of chronic low back pain patients and healthy people during an original and standardized isokinetic protocol. The aim of this study is to determine a potential alteration of muscular aerobic metabolism in low back pain patients, in order to establish the underlying cause of pain and muscular fatigability characterizing low back pain patients. Then, the aim is to determine if functional rehabilitation program can improve it. the unit of care have access to metabolic adaptations in measuring the muscular oxygenation and the pulmonary oxygen consumption, using near infrared spectroscopy and gas analyser.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other University Hospital, Lille trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03055182.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing